Controlling drug-to-antibody ratio and scalable reactors are key to reliable antibody-drug conjugate manufacturing success.

TOKYO, March 12, 2026 3 FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announces its investment in ...

Creative Enzymes stands as a leading provider of enzyme-related services and solutions. Committed to innovation and excellence, the organization supports research in enzymology and biotechnology by ...

随着生物偶联药物领域的飞速发展，以双特异性 ADC、双载荷 ADC 为代表的新一代 ADC，正逐步突破传统 ADC 的发展方向和边界。新型偶联药物正在显著拓展治疗潜力的同时，也对偶联工艺开发提出了更为严苛的CMC挑战，其中包括对 ...

Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ /6821.HK), recently announced that its Fengxian commercial ...

BioDlink, an innovation-driven Contract Development and Manufacturing Organization (CDMO), today announced that it has been named "Emerging CDMO of the Year" at the Asia-Pacific Biopharma Excellence ...

According to MarketsandMarkets™, the Preparative and Process Chromatography Market is projected to grow from about USD 14.32 billion in 2026 to USD 21.50 billion by 2031, at a CAGR of 8.2%.

Discover the transformation of antibody-drug conjugates (ADCs) from experimental to essential in cancer therapy with new ...

Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN021, an independently developed innovative dual payload bispecific antibody-drug conjugate ...

Advances in instrumentation, modeling and control are more fully understood and utilized when assisted by first-principle, ...

T Cells Gain Phagocytic Function via Specific Antigen RecognitionThe research team engineered CD8+ Jurkat T cells to express SVAR16 ...